Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Operating Expenses | 3,797 | 5,347 | 765 | 344 | 252 |
| Operating Income | -3,797 | -5,347 | -765 | -344 | -252 |
| Interest Expense | N/A | N/A | N/A | N/A | 95 |
| Other Income | -1 | 9 | -2 | 53 | -102 |
| Pre-tax Income | -3,798 | -5,338 | -767 | -291 | -449 |
| Income Tax | 0 | 0 | 0 | 0 | -117 |
| Net Income Continuous | -3,798 | -5,338 | -767 | -291 | -332 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 2,267 |
| Net Income | $-3,798 | $-5,338 | $-767 | $-291 | $1,935 |
| EPS Basic Total Ops | -13.40 | -33.40 | -11.80 | -11.25 | 156.00 |
| EPS Basic Continuous Ops | -13.40 | -33.40 | -11.80 | -11.25 | -27.00 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | 183.00 |
| EPS Diluted Total Ops | -13.40 | -33.40 | -11.80 | -11.25 | 156.00 |
| EPS Diluted Continuous Ops | -13.40 | -33.40 | -11.80 | -11.25 | -27.00 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | 182.79 |
| EBITDA(a) | $-3,797 | $-5,347 | $-757 | $-344 | $-354 |